Alliance to Get Blood-Substitute Payment
- Share via
Times Staff and Wire Reports
Alliance Pharmaceutical Corp. said two Johnson & Johnson affiliates will pay the company a milestone payment of $15 million. The San Diego-based company’s shares rose $2 to close at $13.875 on Nasdaq. Ortho Biotech and the R.W. Johnson Pharmaceutical Research Institute decided to make the payment now after reviewing preliminary results of studies conducted with Alliance’s blood substitute.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
